𝔖 Bobbio Scriptorium
✦   LIBER   ✦

T cell-mediated immunity to oncornavirus-induced tumors III. Specific and nonspecific suppression in tumor-bearing mice

✍ Scribed by Christine Plater; Patrice Debré; Jean-Claude Leclerc


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
591 KB
Volume
11
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Suppression of immune response to sheep
✍ Mary A. Pikovski; Y. Ziffroni-Gallon; I. P. Witz 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB 👁 1 views

## Abstract The frequency of rosette‐forming cells (RFC) in spleens of mice immunized with sheep red blood cells (SRBC) was significantly reduced by pretreatment with preparations obtained from tumor extracts. This effect was not produced by preparations obtained by similar methods from normal tiss

Evolution of cell-mediated antitumor imm
✍ Jean Belehradek Jr.; Georges Barski; Monique Thonier 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 French ⚖ 732 KB

## Abstract The evolution of the specific cell‐mediated immune status was studied in C57BL/6 mice bearing a chemically induced syngeneic sarcoma, the TBL CL2 tumor. Peritoneal cells (PC) as the source of immunocompetent cells were repeatedly harvested from the same groups of mice checked in the in

Anti-tumor immunity in b-lymphocyte-depr
✍ Julius Gordon; Howard T. Holden; Shraga Segal; Michael Feldman 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 1016 KB

## Abstract Tumor induction and immunity to tumors were studied following the injection of Moloney sarcoma virus (MSV) into mice whose B‐lymphocyte functions had been suppressed by the chronic administration of anti‐IgM antibodies. Two preparations of MSV were used; one which gives rise to tumors w

Cell-mediated immunity to Moloney sarcom
✍ R. M. Gorczynski; R. A. Knight 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 814 KB

## Abstract Sublethally irradiated BALB/c mice innoculated with Moloney sarcoma virus (MSV‐M) develop progressively growing tumors and die within 30 days of virus innoculation. These animals can be protected from tumor progression (and death) by innoculation of small numbers of MSV‐immune T lymphoc